A
Adaptimmune - ADR (ADAP)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adaptimmune - ADR (ADAP)
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more
- USD0.25
- USD0.25
- USD0.24
- USD1.48
- -13.40%
- 141M
- 459.96k
- 601.39k
- 65M
- 0.20
- -75.50%
Stock News
3 hours ago
Visa's 24/7 war room takes on global cybercriminals
Yahoo
yesterday
Here are the 2 big things we're watching in the stock market in the week ahead
CNBC
yesterday
OPEC+ to boost oil production even more than expected in August
MarketWatch
yesterday
S&P 500: This Is Unusual, Week Starting 7th July (Technical Analysis)
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
